Covishield vaccine induces robust immune responses in Bangladeshi adults

OBJECTIVE: To evaluate severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)-specific antibody responses after Covishield vaccination for 6 months after vaccination. DESIGN: SARS-CoV-2-specific antibody responses were assessed by enzyme-linked immunosorbent assay of the recombinant receptor-b...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhuiyan, Taufiqur Rahman, Akhtar, Marjahan, Khaton, Fatema, Rahman, Sadia Isfat Ara, Ferdous, Jannatul, Alamgir, A.S.M., Rahman, Mahbubur, Kawser, Zannat, Hasan, Imrul, Calderwood, Stephen Beaven, Harris, Jason B., Charles, Richelle C., LaRocque, Regina C., Ryan, Edward Thomas, Banu, Sayera, Shirin, Tahmina, Qadri, Firdausi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9050186/
https://www.ncbi.nlm.nih.gov/pubmed/35720155
http://dx.doi.org/10.1016/j.ijregi.2022.04.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9050186/
https://www.ncbi.nlm.nih.gov/pubmed/35720155
http://dx.doi.org/10.1016/j.ijregi.2022.04.006

Ejemplares similares